Academic Journal
Q1Pediatric Rheumatology
About Pediatric Rheumatology
Pediatric Rheumatology is a scholarly journal published by BioMed Central Ltd. SCImago 2025 lists it in Q1, with an SJR of 0.817 and H-index of 63.
Coverage: 2007-2026. Research categories: Pediatrics, Perinatology and Child Health (Q1); Immunology and Allergy (Q2); Rheumatology (Q2).
Verified field sources
- Journal Impact Factor: 2.3 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Editor(s): Tadej Avčin MD, PhD; Angelo Ravelli MD (Editors-in-Chief) — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-17. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Autoimmune and Inflammatory Disorders Research; Inflammasome and immune disorders; Adolescent and Pediatric Healthcare; Rheumatoid Arthritis Research and Therapies; Systemic Lupus Erythematosus Research; Ocular Diseases and Behçet’s Syndrome.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Clinical features associated with macrophage activation syndrome in juvenile dermatomyositis: implications for early recognition
Li Li, Xiaohua Tan, Shipeng Li, Junmei Zhang et al.
2026-10-01 · DOI: 10.1186/s12969-026-01279-4Adherence to treat-to-target recommendations in juvenile idiopathic arthritis in clinical practice
S. De Roock, P. C. E. Hissink Muller, R. S. M. Yeung, S. J. Vastert et al.
2026-09-23 · DOI: 10.1186/s12969-026-01265-wImplementation of a comprehensive healthcare transition program incorporating social determinants of health screening for adolescents with rheumatic disease
Sarah Barrientos, Morayah Ciprien, Elinore Benett, Cori Christenholz et al.
2026-09-23 · DOI: 10.1186/s12969-026-01271-yProceedings of the 33rd European Paediatric Rheumatology Congress
2026-09-16 · DOI: 10.1186/s12969-026-01260-1Secukinumab in the management of generalized pustular psoriasis comorbidity with nephrotic syndrome in a toddler with IL36RN variant
Weina Zhang, Xiaohong Wu, Min Li, Yong Cai et al.
2026-09-14 · DOI: 10.1186/s12969-026-01277-6Clinimetrics in juvenile localized scleroderma: advances and future directions
Suzanne C. Li, Clare E. Pain
2026-09-14 · DOI: 10.1186/s12969-026-01278-5Health-related quality of life in childhood arthritis: the impact of generic versus disease-specific instruments
Jelleke B. de Jonge, Sytze de Roock, Nele Grundhoefer, Deborah A. Marshall et al.
2026-09-12 · DOI: 10.1186/s12969-026-01274-9Outcome measures in paediatric rheumatology: the contribution of the Paediatric Rheumatology INternational Trials Organisation and the Pediatric Rheumatology Collaborative Study Group
Saverio La Bella, Alessandra Alongi, Hermine I. Brunner, Angelo Ravelli et al.
2026-09-09 · DOI: 10.1186/s12969-026-01273-wMuscle function in children with juvenile idiopathic arthritis: the Linking Exercise, Activity and Pathophysiology (LEAP) study
Johannes Roth, Heather Macdonald, Kristin Houghton, Michele Gibbon et al.
2026-09-09 · DOI: 10.1186/s12969-026-01268-7Design of a prediction system for intravenous immunoglobulin resistance in hospitalized Kawasaki disease patients with artificial intelligence based on machine learning
Arash Sang, Amir Rahdar, Parisa Afzali, Fatemeh Tahghighi et al.
2026-09-09 · DOI: 10.1186/s12969-026-01269-6The enduring role of sulfasalazine in the treatment of juvenile idiopathic arthritis: a retrospective cohort study on safety and effectiveness
Alexia D’hont, Benson Ogunjimi, Rik Joos
2026-09-08 · DOI: 10.1186/s12969-026-01270-zAssociation of persistent oxidative stress markers with coronary artery abnormalities in Kawasaki disease patients on follow-up
Rajni Kumrah, Taru Goyal, Manphool Singhal, Prateek Bhatia et al.
2026-09-04 · DOI: 10.1186/s12969-026-01249-wLong-term outcome of bisphosphonate therapy in paediatric CNO: a single-centre cohort study
Sarah Remtoula, Federica Anselmi, Justin Ulm, Linda Rossi-Semerano et al.
2026-09-02 · DOI: 10.1186/s12969-026-01253-0Adolescent and caregiver clinical encounters with healthcare providers during their diagnostic journey with chronic musculoskeletal pain: implications for pediatric rheumatology
Titilola Falasinnu, Alfonso Gonzalez, Amora Robinson, Andrea Hughes et al.
2026-09-01 · DOI: 10.1186/s12969-026-01263-yEarly-life physical activity and risk of juvenile idiopathic arthritis: a longitudinal ABIS cohort study using a symptom-free baseline design
Noman Sohail, Erik Kindgren, Johnny Ludvigsson
2026-09-01 · DOI: 10.1186/s12969-026-01266-9Neurological manifestations and vasculopathy in PLCG2–associated antibody deficiency and immune dysregulation (APLAID): a case series
Kosar Asna Ashari, Rebecca MacRae, David P. Hoytema van Konijnenburg, Craig D. Platt et al.
2026-08-29 · DOI: 10.1186/s12969-026-01227-2Neonatal Aicardi–Goutières syndrome presenting with macrophage activation syndrome-like hyperinflammation and severe congenital glaucoma: a case report
Murat Konak, Banu Bozkurt, Gülay Ceylaner, Müşerref Kasap Cüceoğlu et al.
2026-08-24 · DOI: 10.1186/s12969-026-01264-xChallenges in linking interferon signatures to clinical trajectories in juvenile idiopathic arthritis
Laura Scagnellato, Melissa Kartawinata, Wei-Yu Lin, Stephanie Shoop-Worrall et al.
2026-08-18 · DOI: 10.1186/s12969-026-01256-xCross-cultural adaptation and validation of the Localised Scleroderma Quality of Life Instrument (LoSQI): an international study
Christina K. Zigler, Kaveh Ardalan, Juhi Gupta, Ivan Foeldvari et al.
2026-08-17 · DOI: 10.1186/s12969-026-01257-wClinical outcomes of rivaroxaban and warfarin for anticoagulation in children with giant coronary artery aneurysms after Kawasaki disease
Penghui Yang, Jinlin Wu, Lei Liu, Li Zhao et al.
2026-08-10 · DOI: 10.1186/s12969-026-01259-8Reviews
Community Reviews
Version History
October 2, 2026 at 8:56 pm
October 2, 2026